Human vascularized bile duct-on-a chip: a multi-cellular micro-physiological system for studying cholestatic liver disease

Author:

Du YuORCID,de Jong Iris E M,Gupta Kapish,Waisbourd-Zinman Orit,Har-Zahav Adi,Soroka Carol J,Boyer James L,Llewellyn Jessica,Liu Chengyang,Naji Ali,Polacheck William J,Wells Rebecca GORCID

Abstract

Abstract Exploring the pathogenesis of and developing therapies for cholestatic liver diseases such as primary sclerosing cholangitis (PSC) remains challenging, partly due to a paucity of in vitro models that capture the complex environments contributing to disease progression and partly due to difficulty in obtaining cholangiocytes. Here we report the development of a human vascularized bile duct-on-a-chip (VBDOC) that uses cholangiocyte organoids derived from normal bile duct tissue and human vascular endothelial cells to model bile ducts and blood vessels structurally and functionally in three dimensions. Cholangiocytes in the duct polarized, formed mature tight junctions and had permeability properties comparable to those measured in ex vivo systems. The flow of blood and bile was modeled by perfusion of the cell-lined channels, and cholangiocytes and endothelial cells displayed differential responses to flow. We also showed that the device can be constructed with biliary organoids from cells isolated from both bile duct tissue and the bile of PSC patients. Cholangiocytes in the duct became more inflammatory under the stimulation of IL-17A, which induced peripheral blood mononuclear cells and differentiated Th17 cells to transmigrate across the vascular channel. In sum, this human VBDOC recapitulated the vascular-biliary interface structurally and functionally and represents a novel multicellular platform to study inflammatory and fibrotic cholestatic liver diseases.

Funder

AASLD Foundation/PSC Partners Seeking a Cure

Fred and Suzanne Biesecker Pediatric Liver Center at the Children’s Hospital of Philadelphia

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

IOP Publishing

Subject

Biomedical Engineering,General Medicine,Biomaterials,Biochemistry,Bioengineering,Biotechnology

Reference32 articles.

1. Primary sclerosing cholangitis;Dyson;Lancet,2018

2. Primary sclerosing cholangitis;Lazaridis;New Engl. J. Med.,2016

3. Return to sender: lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitis;de Krijger;J. Hepatol.,2019

4. Cholangiocyte pathobiology;Banales;Nat. Rev. Gastroenterol. Hepatol.,2019

5. Primary sclerosing cholangitis—a comprehensive review;Karlsen;J. Hepatol.,2017

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Engineered Biomaterials and Model Systems to Study YAP/TAZ in Cancer;ACS Biomaterials Science & Engineering;2024-08-27

2. Liver-on-chips for drug discovery and development;Materials Today Bio;2024-08

3. Biliary atresia;Nature Reviews Disease Primers;2024-07-11

4. Human Hepatobiliary Organoids: Recent Advances in Drug Toxicity Verification and Drug Screening;Biomolecules;2024-07-04

5. Vascular microphysiological systems;Current Opinion in Hematology;2024-01-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3